License for Meditoxin Botox Pulled
20 June, 2020
The federal government on Thursday banned Korea's first type of botox products created by Medytox since the firm adulterated them and doctored paperwork.
Meditoxin was being among the most popular botox products in Korea for days gone by 14 years. But the biotech organization was caught applying an unapproved ingredient and doctoring related records between 2012 and 2015.
The Ministry of Foodstuff and Drug Safety said it really is revoking the licenses for packs of 50, 100 and 150 Meditoxin doses effective June 25 but added they pose no significant health risks for people who've already used them.
Meditoxin accounted for 30 to 40 percent of Korea's W150-billion botox market and thousands of people have used them during the last 14 years (US$1=W1,210).
Medytox vowed to data file a good lawsuit against the ministry's order, saying that a ban is too harsh when the ministry admitted that it poses zero health risk.
A staffer at the Korean Contemporary society of Plastic material and Reconstructive Surgeons said the element in question "dissipates inside the body in 6 to 8 months and disappears."
Source: